STOK

Stoke Therapeutics Inc. Common Stock (STOK)

Stock · NASDAQ · Health Care

$31.61as of 8/28/2026

Price chart

Open in TradingView

Active signals

200 SMA Touch84.4%Support Reject21.4%Volume Spike15.2%RSI Negative Divergence12.6%
Resistance level
$31.69
Industry
Biotechnology: Pharmaceutical Preparations

About STOK

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of au…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
170

Fundamentals

1-day range
$31.49$32.55
Market cap
$2.06B
P/E (trailing)
—
P/E (forward)
-9.00
EPS (trailing)
$-3.36
Dividend yield
—
Beta
1.23
Avg. volume
861.7K
52-week range
$18.8$40.22
Next earnings: November 3, 2026 · EPS estimate $-0.91confirmed

How Stoke Therapeutics Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$184.42MR&D$137.92M (75%)SG&A$67.09M (36%)STOK

Source: 10-K filed Mar 16, 2026 · via SEC EDGAR / Finnhub

Forecasts

13 analyst ratings

Buy 95%
Hold 5%
Sell 0%
1-year price forecast
High
$60
+89.8%
Median
$44
+39.2%
Low
$35
+10.7%

Stoke Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • STOK
    Stoke Therapeutics Inc. Common Stock
    $31.61
    ▼ 3.01%
    Market cap $2.06BP/E —
    $18.8$40.22
  • HCM
    HUTCHMED (China) Limited American Depositary Shares
    $12.4
    ▼ 0.12%
    Market cap $2.06BP/E —
  • ZBIO
    Zenas BioPharma Inc. Common Stock
    $31.29
    ▼ 4.08%
    Market cap $2.03BP/E —
    $13.5$44.6
  • AUPH
    Aurinia Pharmaceuticals Inc Ordinary Shares
    $16.3
    ▼ 1.09%
    Market cap $2.10BP/E 6.39
    $10.34$19.25
  • NUVB
    Nuvation Bio Inc. Class A Common Stock
    $6.67
    ▼ 4.65%
    Market cap $2.13BP/E —
    $2.87$9.75
  • BHVN
    Biohaven Ltd. Common Shares
    $15.42
    ▼ 4.37%
    Market cap $2.17BP/E —
    $7.48$18.57
  • SLS
    SELLAS Life Sciences Group Inc. Common Stock
    $13.17
    ▼ 13.45%
    Market cap $2.18BP/E —

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
242.8K
Disposed
167.5K
  • Barry Ticho · August 3, 2026 · Sale
    1.3K @ $29.45
  • Barry Ticho · August 3, 2026 · Sale
    5.9K @ $28.95
  • Harrison Seth Loring · July 16, 2026 · Gift
    17.8K
  • Harrison Seth Loring · July 16, 2026 · Gift
    29.7K
  • Harrison Seth Loring · July 16, 2026 · Gift
    7.6K
  • Harrison Seth Loring · July 16, 2026 · Gift
    19.4K
  • Harrison Seth Loring · July 16, 2026 · Gift
    21.0K
  • Harrison Seth Loring · July 16, 2026 · Gift
    11.7K
  • Harrison Seth Loring · July 16, 2026 · Gift
    14.8K
  • Harrison Seth Loring · July 16, 2026 · Gift
    29.6K
  • McCauley Thomas · July 15, 2026 · Grant
    225.0K
  • Barry Ticho · July 1, 2026 · Sale
    500 @ $33.27
  • Barry Ticho · July 1, 2026 · Sale
    6.7K @ $32.62
  • Jonathan Allan · June 16, 2026 · Sale
    1.5K @ $29.95
  • Adrian R. Krainer · June 3, 2026 · Grant
    17.8K

Institutional Ownership

March 31, 2026

Total shares held
70.34M
Total value held
$2.22B
Institutional holders
191
Top holders this quarter
  • Unknown5.62M
  • Unknown5.39M
  • Unknown5.38M
  • Unknown4.76M
  • Unknown4.16M
  • Unknown3.42M
  • Unknown3.34M
  • Unknown3.17M
  • Unknown3.10M
  • Unknown2.55M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.